Get started
Author

Laure Garrigue‐Antar

Observed names: Garrigue-Antar, Laure, L Garrigue, L Garrigue-Antar, L. GARRIGUE-ANTAR, L. Garrigue, L. Garrigue-Antar, Laure GARRIGUE-ANTAR, Laure Garrigue-Antar, Laure Garrigue-antar, Laure Guarrigue‐Antar
Observed institutions: University of Maryland, Baltimore, Centre National de la Recherche Scientifique, École nationale des ponts et chaussées, Inserm, Université Paris-Est Créteil, Wellcome Centre for Cell-Matrix Research, University of Manchester, Centre Hospitalier Universitaire de Nantes, Yale University, Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers, Laboratoire Eau, Environnement et Systèmes Urbains, Laboratoire de Recherche sur la Croissance Cellulaire, la Réparation et la Régénération Tissulaires, Institut Polytechnique de Paris, Université de Nantes, Pôle de recherche et d'enseignement supérieur Université Paris-Est, Nantes Université
ORCID: 0000-0001-6331-8882
Observed ORCID: 0000-0001-6331-8882
OpenAlex ID: A5049660140
Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor
2007 · Thierry Walzer, Laura Chiossone, et al. · Nature Immunology · 450
Missense mutations of the transforming growth factor beta type II receptor in human head and neck squamous carcinoma cells.
1995 · L Garrigue-Antar, T Muñoz-Antonia, et al. · PubMed · 217
Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer.
1998 · T Chen, D Carter, et al. · PubMed · 149
The Soluble α Chain of Interleukin-15 Receptor: A Proinflammatory Molecule Associated with Tumor Progression in Head and Neck Cancer
2008 · Cécile Badoual, Grégory Bouchaud, et al. · Cancer Research · 98
PDF
Bone Morphogenetic Protein-1 (BMP-1)
2003 · Nichola Hartigan, Laure Garrigue-Antar, et al. · Journal of Biological Chemistry · 89
Tumor targeting of the IL‐15 superagonist RLI by an anti‐GD2 antibody strongly enhances its antitumor potency
2013 · Marie Vincent, Anne Bessard, et al. · International Journal of Cancer · 70
PDF
The role of transforming growth factor beta 1 in the fibroblastic reaction associated with rat colorectal tumor development.
1994 · B Lieubeau, L Garrigue, et al. · PubMed · 70
Glycosaminoglycans as Potential Regulators of Osteoprotegerin Therapeutic Activity in Osteosarcoma
2009 · Francois Lamoureux, Gaëlle Picarda, et al. · Cancer Research · 59
Frequent inactivation of the transforming growth factor beta type II receptor in small-cell lung carcinoma cells.
1997 · R R de Jonge, L Garrigue-Antar, et al. · PubMed · 57
The Exon-3-Encoded Domain of IL-15Rα Contributes to IL-15 High-Affinity Binding and Is Crucial for the IL-15 Antagonistic Effect of Soluble IL-15Rα
2008 · Grégory Bouchaud, Laure Garrigue-Antar, et al. · Journal of Molecular Biology · 56
Post-translational Modification of Bone Morphogenetic Protein-1 Is Required for Secretion and Stability of the Protein
2002 · Laure Garrigue-Antar, Nichola Hartigan, et al. · Journal of Biological Chemistry · 55
PDF
Loss of transforming growth factor-beta type II receptor gene expression in primary human esophageal cancer.
1996 · L Garrigue-Antar, R F Souza, et al. · PubMed · 55
New Roles of Glycosaminoglycans in α-Synuclein Aggregation in a Cellular Model of Parkinson Disease
2015 · Sonia Lehri-Boufala, Mohand-Ouidir Ouidja, et al. · PLoS ONE · 48
PDF
Identification of the Minimal Domain Structure of Bone Morphogenetic Protein-1 (BMP-1) for Chordinase Activity
2005 · Vasiliki Petropoulou, Laure Garrigue-Antar, et al. · Journal of Biological Chemistry · 48
Identification of Amino Acid Residues in Bone Morphogenetic Protein-1 Important for Procollagen C-proteinase Activity
2001 · Laure Garrigue-Antar, Catherine Barker, et al. · Journal of Biological Chemistry · 40
PDF
Highly potent anti-CD20-RLI immunocytokine targeting established human B lymphoma in SCID mouse
2014 · Marie Vincent, Géraldine Teppaz, et al. · mAbs · 38
PDF
Deletion of Epidermal Growth Factor-like Domains Converts Mammalian Tolloid into a Chordinase and Effective Procollagen C-proteinase
2004 · Laure Garrigue-Antar, Vincent François, et al. · Journal of Biological Chemistry · 35
PDF
Alterations of transforming growth factor-beta 1 receptor type II occur in ulcerative colitis-associated carcinomas, sporadic colorectal neoplasms, and esophageal carcinomas, but not in gastric neoplasms.
1996 · R F Souza, L Garrigue-Antar, et al. · PubMed · 29
Functional Characterization of a Chimeric Soluble Fas Ligand Polymer with In Vivo Anti-Tumor Activity
2013 · Sophie Daburon, Christel Devaud, et al. · PLoS ONE · 28
PDF
Comprehensive analysis of a widely pharmaceutical, furosemide, and its degradation products in aquatic systems: Occurrence, fate, and ecotoxicity
2024 · Fidji Sandré, Régis Moilleron, et al. · Environmental Pollution · 27
PDF
Modulation of Inflammation by Cicaderma Ointment Accelerates Skin Wound Healing
2012 · Christophe Morin, Audrey Roumegous, et al. · Journal of Pharmacology and Experimental Therapeutics · 25
Definition and Characterization of an Inhibitor for Interleukin-31
2010 · Emilie Venereau, Caroline Diveu, et al. · Journal of Biological Chemistry · 25
PDF
Structural and functional evidence for a substrate exclusion mechanism in mammalian tolloid like‐1 (TLL‐1) proteinase
2009 · Richard Berry, Thomas A. Jowitt, et al. · FEBS Letters · 24
PDF
Occurrence and fate of an emerging drug pollutant and its by-products during conventional and advanced wastewater treatment: Case study of furosemide
2023 · Fidji Sandre, Nina Huynh, et al. · Chemosphere · 23
PDF
Functional characterization of transforming growth factor beta type II receptor mutants in human cancer.
1998 · M De, W Yan, et al. · PubMed · 18
Works count: 78
Citation count: 1,952
H-index: 23
I10-index: 32
Year
Topic
Type